The effects of lutein on cardiometabolic health across the life course: A systematic review and meta-analysis

American Journal of Clinical Nutrition

Volumn 103, Issue 2, 2016, Pages 481-494

  Leermakers, Elisabeth T M ^a   Darweesh, Sirwan K L ^a   Baena, Cristina P ^b   Moreira, Eduardo M ^a   Van Lent, Debora Melo ^a   Tielemans, Myrte J ^a   Muka, Taulant ^a   Vitezova, Anna ^a   Chowdhury, Rajiv ^c   Bramer, Wichor M ^a   Kiefte De Jong, Jessica C ^a,d   Felix, Janine F ^a   Franco, Oscar H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Antioxidant; Cardiometabolic health; Life course; Lutein; Systematic review

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; GAMMA INTERFERON; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 1; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; XANTHOPHYLL; ANTIOXIDANT; BIOLOGICAL MARKER; CAROTENOID;

ARTICLE; ATHEROSCLEROSIS; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COCHRANE LIBRARY; COMPARATIVE STUDY; CONCENTRATION PROCESS; CROSS-SECTIONAL STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE ASSOCIATION; EMBASE; HEALTH STATUS; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INTERVENTION STUDY; ISCHEMIC HEART DISEASE; LIFE CYCLE; LIPID BLOOD LEVEL; LOW RISK POPULATION; MEDLINE; META ANALYSIS (TOPIC); METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PREGNANCY; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW; VITAMIN BLOOD LEVEL; WEB OF SCIENCE; AGE; BLOOD; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIET; DIETARY SUPPLEMENT; EVIDENCE BASED MEDICINE; GLUCOSE METABOLISM DISORDERS; META ANALYSIS;

AGE FACTORS; ANTIOXIDANTS; BIOMARKERS; CARDIOVASCULAR DISEASES; CAROTENOIDS; DIABETES MELLITUS, TYPE 2; DIET; DIETARY SUPPLEMENTS; EVIDENCE-BASED MEDICINE; GLUCOSE METABOLISM DISORDERS; HUMANS; LUTEIN; METABOLIC SYNDROME X; RISK FACTORS;

EID: 84956951503     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.115.120931     Document Type: Article

References (99)

1. Kijlstra A, Tian Y, Kelly ER, Berendschot TTJM. Lutein: More than just a filter for blue light. Prog Retin Eye Res 2012;31:303-15.
2. Sujak A, Gabrielska J, Grudzinski W, Borc R, Mazurek P, Gruszecki WI. Lutein and zeaxanthin as protectors of lipid membranes against oxidative damage: The structural aspects. Arch Biochem Biophys 1999;371:301-7.
3. Voutilainen S, Nurmi T, Mursu J, Rissanen TH. Carotenoids and cardiovascular health. Am J Clin Nutr 2006;83(6):1265-71.
4. Karppi J, Laukkanen JA, Makikallio TH, Ronkainen K, Kurl S. Low beta-carotene concentrations increase the risk of cardiovascular disease mortality among Finnish men with risk factors. Nutr Metab Cardiovasc Dis 2012;22:921-8.
5. Fortmann SP, Burda BU, Senger CA, Lin JS, Whitlock EP. Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer: an updated systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 2013;159:824-34.
6. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention-systematic review and meta-analysis. JAMA 2007;297:842-57.
7. Sommer A, Vyas KS. A global clinical view on vitamin A and carotenoids. Am J Clin Nutr 2012;96:1204S-6S.
8. Beydoun MA, Canas JA, Beydoun HA, Chen XL, Shroff MR, Zonderman AB. Serum antioxidant concentrations and metabolic syndrome are associated among US adolescents in recent national surveys. J Nutr 2012;142:1693-704.
9. CapeDing R, Gepanayao CP, Calimon N, Lebumfacil J, Davis AM, Stouffer N, Harris BJ. Lutein-fortified infant formula fed to healthy term infants: evaluation of growth effects and safety. Nutr J 2010;9(1): 22.
10. Masters ET, Jedrychowski W, Schleicher RL, Tsai WY, Tu YH, Camann D, Tang D, Perera FP. Relation between prenatal lipid-soluble micronutrient status, environmental pollutant exposure, and birth outcomes. Am J Clin Nutr 2007;86:1139-45.
11. Melikian G, Mmiro F, Ndugwa C, Perry R, Jackson JB, Garrett E, Tielsch J, Semba RD. Relation of vitamin A and carotenoid status to growth failure and mortality among Ugandan infants with human immunodeficiency virus. Nutrition 2001;17:567-72.
12. Almushatat ASK, Talwar D, McArdle PA, Williamson C, Sattar N, O'Reiliy DSJ, Underwood MA, McMillan DC. Vitamin antioxidants, lipid peroxidation and the systemic inflammatory response in patients with prostate cancer. Int J Cancer 2006;118:1051-3.
13. Ascherio A, Rimm EB, Hernan MA, Giovannucci E, Kawachi I, Stampfer MJ, Willett WC. Relation of consumption of vitamin E, vitamin C, and carotenoids to risk for stroke among men in the United States. Ann Intern Med 1999;130:963-70.
14. Bates CJ, Hamer M, Mishra GD. Redox-modulatory vitamins and minerals that prospectively predict mortality in older British people: the National Diet and Nutrition Survey of people aged 65 years and over. Br J Nutr 2011;105:123-32.
15. Ben Amara N, Tourniaire F, Maraninchi M, Attia N, Amiot-Carlin MJ, Raccah D, Valero R, Landrier JF, Darmon P. Independent positive association of plasma (beta)-carotene concentrations with adiponectin among non-diabetic obese subjects. Eur J Nutr 2015;54:447-54.
16. Beydoun MA, Shroff MR, Chen X, Beydoun HA, Wang Y, Zonderman AB. Serum antioxidant status is associated with metabolic syndrome among U.S. adults in recent national surveys. J Nutr 2011;141:903-13.
17. Blondin SA, Yeung EH, Mumford SL, Zhang C, Browne RW, Wactawski-Wende J, Schisterman EF. Serum retinol and carotenoids in association with biomarkers of insulin resistance among premenopausal women. ISRN Nutr 2013;2013:619516.
18. Brighenti F, Valtuena S, Pellegrini N, Ardigo D, Del Rio D, Salvatore S, Piatti P, Serafini M, Zavaroni I. Total antioxidant capacity of the diet is inversely and independently related to plasma concentration of high-sensitivity C-reactive protein in adult Italian subjects. Br J Nutr 2005;93:619-25.
19. Buijsse B, Feskens EJM, Kwape L, Kok FJ, Kromhout D. Both (alpha)-and (beta)-carotene, but not tocopherols and vitamin C, are inversely related to 15-year cardiovascular mortality in Dutch elderly men. J Nutr 2008;138:344-50.
20. Coyne T, Ibiebele TI, Baade PD, Dobson A, McClintock C, Dunn S, Leonard D, Shaw J. Diabetes mellitus and serum carotenoids: finDings of a population-based study in Queensland, Australia. Am J Clin Nutr 2005;82:685-93.
21. Coyne T, Ibiebele TI, Baade PD, McClintock CS, Shaw JE. Metabolic syndrome and serum carotenoids: finDings of a cross-sectional study in Queensland, Australia. Br J Nutr 2009;102:1668-77.
22. D'Adamo CR, Miller RR, Shardell MD, Orwig DL, Hochberg MC, Ferrucci L, Semba RD, Yu-Yahiro JA, Magaziner J, Hicks GE. Higher serum concentrations of dietary antioxidants are associated with lower levels of inflammatory biomarkers during the year after hip fracture. Clin Nutr 2012;31:659-65.
23. D'Odorico A, Martines D, Kiechl S, Egger G, Oberhollenzer F, Bonvicini P, Sturniolo GC, Naccarato R, Willeit J. High plasma levels of (alpha)-and (beta)-carotene are associated with a lower risk of atherosclerosis: results from the Bruneck study. Atherosclerosis 2000;153:231-9.
24. Dwyer JH, Navab M, Dwyer KM, Hassan K, Sun P, Shircore A, Hama-Levy S, Hough G, Wang XP, Drake T. Oxygenated carotenoid lutein and progression of early atherosclerosis-the Los Angeles Atherosclerosis Study. Circulation 2001;103:2922-7.
25. Ford ES, Will JC, Bowman BA, Narayan KMV. Diabetes mellitus and serum carotenoids: finDings from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 1999;149:168-76.
26. Ford ES, Giles WH. Serum vitamins, carotenoids, and angina pectoris: finDings from the National Health and Nutrition Examination Survey III. Ann Epidemiol 2000;10:106-16.
27. Gey KF, Ducimetiere P, Evans A, Amouyel P, Arveiler D, Ferrieres J, Luc G, Kee F, Bingham A, Yarnell J. Low plasma retinol predicts coronary events in healthy middle-aged men: the PRIME Study. Atherosclerosis 2010;208:270-4.
28. Granado-Lorencio F, Olmedilla-Alonso B, Blanco-Navarro I, Botella-Romero F, Simal-Anton A. Assessment of carotenoid status and the relation to glycaemic control in type I diabetics: a follow-up study. Eur J Clin Nutr 2006;60:1000-8.
29. Graydon R, Hogg RE, Chakravarthy U, Young IS, Woodside JV. The effect of lutein-and zeaxanthin-rich foods v. supplements on macular pigment level and serological markers of endothelial activation, inflammation and oxidation: pilot studies in healthy volunteers. Br J Nutr 2012;108:334-42.
30. Hak AE, Stampfer MJ, Campos H, Sesso HD, Gaziano JM, Willett W, Ma J. Plasma carotenoids and tocopherols and risk of myocardial infarction in a low-risk population of US male physicians. Circulation 2003;108:802-7.
31. Hak AE, Ma J, Powell CB, Campos H, Gaziano JM, Willett WC, Stampfer MJ. Prospective study of plasma carotenoids and tocopherols in relation to risk of ischemic stroke. Stroke 2004;35:1584-8.
32. Hirvonen T, Virtamo J, Korhonen P, Albanes D, Pietinen P. Intake of flavonoids, carotenoids, vitamins C and E, and risk of stroke in male smokers. Stroke 2000;31:2301-6.
33. Hozawa A, Jacobs DR, Steffes MW, Gross MD, Steffen LM, Lee DH. Associations of serum carotenoid concentrations with the development of diabetes and with insulin concentration: interaction with smoking-The Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Epidemiol 2006;163:929-37.
34. Hozawa A, Jacobs DR, Steffes MW, Gross MD, Steffen LM, Lee DH. Relationships of circulating carotenoid concentrations with several markers of inflammation, oxidative stress, and endothelial dysfunction: the Coronary Artery Risk Development in Young Adults (CARDIA)/Young Adult Longitudinal Trends in Antioxidants (YALTA) Study. Clin Chem 2007;53:447-55.
35. Hozawa A, Jacobs DR, Steffes MW, Gross MD, Steffen LM, Lee DH. Circulating carotenoid concentrations and incident hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) study. J Hypertens 2009;27:237-42.
36. Iribarren C, Folsom AR, Jacobs DR, Gross MD, Belcher JD, Eckfeldt JH. Association of serum vitamin levels, LDL susceptibility to oxidation, and autoantibodies against MDA-LDL with carotid atherosclerosis-a case-control study. Arterioscl Throm Vasc Biol 1997;17: 1171-7.
37. Ito Y, Suzuki K, Ishii J, Hishida H, Tamakoshi A, Hamajima N, Aoki K. A population-based follow-up study on mortality from cancer or cardiovascular disease and serum carotenoids, retinol and tocopherols in Japanese inhabitants. Asian Pac J Cancer Prev 2006; 7:533-46.
38. Kabagambe EK, Furtado J, Baylin A, Campos H. Some dietary and adipose tissue carotenoids are associated with the risk of nonfatal acute myocardial infarction in Costa Rica. J Nutr 2005;135:1763-9.
39. Karppi J, Kurl S, Laukkanen JA, Rissanen TH, Kauhanen J. Plasma carotenoids are related to intima-media thickness of the carotid artery wall in men from eastern Finland. J Intern Med 2011;270:478-85.
40. Kataja-Tuomola MK, Kontto JP, Mannisto S, Albanes D, Virtamo J. Intake of antioxidants and risk of type 2 diabetes in a cohort of male smokers. Eur J Clin Nutr 2011;65:590-7.
41. Klipstein-Grobusch K, Launer LJ, Geleijnse JM, Boeing H, Hofman A, Witteman JCM. Serum carotenoids and atherosclerosis-the Rotterdam Study. Atherosclerosis 2000;148:49-56.
42. Knekt P, Ritz J, Pereira MA, O'Reilly EJ, Augustsson K, Fraser GE, Goldbourt U, Heitmann BL, Hallmans G, Liu SM. Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts. Am J Clin Nutr 2004;80:1508-20.
43. Koh WP, Yuan JM,Wang R, Lee YP, Lee BL, Yu MC, Ong CN. Plasma carotenoids and risk of acute myocardial infarction in the Singapore Chinese Health Study. Nutr Metab Cardiovasc Dis 2011;21:685-90.
44. Mayne ST, Cartmel B, Lin HQ, Zhang TZ, Goodwin WJ. Low plasma lycopene concentration is associated with increased mortality in a cohort of patients with prior oral, pharynx or larynx cancers. J Am Coll Nutr 2004;23:34-42.
45. Montonen J, Knekt P, Jarvinen R, Reunanen A. Dietary antioxidant intake and risk of type 2 diabetes. Diabetes Care 2004;27:362-6.
46. Murr C, Winklhofer-Roob BM, Schroecksnadel K, Maritschnegg M, Mangge H, Bohm BO, Winkelmann BR, Marz W, Fuchs D. Inverse association between serum concentrations of neopterin and antioxidants in patients with and without angiographic coronary artery disease. Atherosclerosis 2009;202:543-9.
47. Nakamura M, Sugiura M, Aoki N. High beta-carotene and betacryptoxanthin are associated with low pulse wave velocity. Atherosclerosis 2006;184:363-9.
48. Nieto FJ, Iribarren C, Gross MD, Comstock GW, Cutler RG. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? Atherosclerosis 2000;148:131-9.
49. Olea JL, Aragon JA, Zapata ME, Tur JA. [Characteristics of patients with wet age-related macular degeneration and low intake of lutein and zeaxanthin] (in Spanish). Arch Soc Esp Oftalmol 2012;87:112-8.
50. Osganian SK, Stampfer MJ, Rimm E, Spiegelman D, Manson JE, Willett WC. Dietary carotenoids and risk of coronary artery disease in women. Am J Clin Nutr 2003;77:1390-9.
51. Polidori MC, Pratico D, Parente B, Mariani E, Cecchetti R, Yao Y, Sies H, Cao P, Mecocci P, Stahl W. Elevated lipid peroxidation biomarkers and low antioxidant status in atherosclerotic patients with increased carotid or iliofemoral intima media thickness. J Investig Med 2007;55: 163-7.
52. Renzi LM, Hammond BR, Dengler M, Roberts R. The relation between serum lipids and lutein and zeaxanthin in the serum and retina: results from cross-sectional, case-control and case study designs. Lipids Health Dis 2012;11:33.
53. Rerksuppaphol S, Chansiri K, Rerksuppaphol L, Loetthiraphan S, Chansiri G. Correlation of low levels of serum carotenoids with increased risk of cardiovascular diseases. Biomedicine 2010;30:436-43.
54. Ribaya-Mercado JD, Ordovas JM, Russell RM. Effect of (beta)-carotene supplementation on the concentrations and distribution of carotenoids, vitamin E, vitamin A, and cholesterol in plasma lipoprotein and non-lipoprotein fractions in healthy older women. J Am Coll Nutr 1995;14:614-20.
55. Rowley K, Walker KZ, Cohen J, Jenkins AJ, O'Neal D, Su Q, Best JD, O'Dea K. Inflammation and vascular endothelial activation in an Aboriginal population: relationships to coronary disease risk factors and nutritional markers. Med J Aust 2003;178:495-500.
56. Ruiz Rejón F, Martin-Pena G, Granado F, Ruiz-Galiana J, Blanco I, Olmedilla B. Plasma status of retinol, (alpha)-and (gamma)-tocopherols, and main carotenoids to first myocardial infarction: case control and follow-up study. Nutrition 2002;18:26-31.
57. Sesso HD, Buring JE, Norkus EP, Gaziano JM. Plasma lycopene, other carotenoids, and retinol and the risk of cardiovascular disease in women. Am J Clin Nutr 2004;79:47-53.
58. Sesso HD, Buring JE, Norkus EP, Gaziano JM. Plasma lycopene, other carotenoids, and retinol and the risk of cardiovascular disease in men. Am J Clin Nutr 2005;81:990-7.
59. Shardell MD, Alley DE, Hicks GE, El-Kamary SS, Miller RR, Semba RD, Ferrucci L. Low-serum carotenoid concentrations and carotenoid interactions predict mortality in US adults: the Third National Health and Nutrition Examination Survey. Nutr Res 2011;31:178-89.
60. Sluijs I, Beulens JWJ, Grobbee DE, van der Schouw YT. Dietary carotenoid intake is associated with lower prevalence of metabolic syndrome in middle-aged and elderly men. J Nutr 2009;139:987-92.
61. Street DA, Comstock GW, Salkeld RM, Schuep W, Klag MJ. Serum antioxidants and myocardial infarction: are low levels of carotenoids and (alpha)-tocopherol risk factors for myocardial infarction? Circulation 1994;90:1154-61.
62. Sugiura M, Nakamura M, Ikoma Y, Yano M, Ogawa K, Matsumoto H, Kato M, Ohshima M, Nagao A. The homeostasis model assessmentinsulin resistance index is inversely associated with serum carotenoids in non-diabetic subjects. J Epidemiol 2006;16:71-8.
63. Sugiura M, Nakamura M, Ogawa K, Ikoma Y, Matsumoto H, Ando F, Shimokata H, Yano M. Associations of serum carotenoid concentrations with the metabolic syndrome: interaction with smoking. Br J Nutr 2008;100:1297-306.
64. Sundl I, Roob JM, Meinitzer A, Tiran B, Khoschsorur G, Haditsch B, Holzer H, Winklhofer-Roob BM. Antioxidant status of patients on peritoneal dialysis: associations with inflammation and glycoxidative stress. Perit Dial Int 2009;29:89-101.
65. Suzuki K, Inoue T, Hashimoto S, Ochiai J, Kusuhara Y, Ito Y, Hamajima N. Association of serum carotenoids with high molecular weight adiponectin and inflammation markers among Japanese subjects. Clin Chim Acta 2010;411:1330-4.
66. Suzuki K, Ito Y, Inoue T, Hamajima N. Inverse association of serum carotenoids with prevalence of metabolic syndrome among Japanese. Clin Nutr 2011;30:369-75.
67. Tavani A, Gallus S, Negri E, Parpinel M, La Vecchia C. Dietary intake of carotenoids and retinol and the risk of acute myocardial infarction in Italy. Free Radic Res 2006;40:659-64.
68. Törnwall ME, Virtamo J, Haukka JK, Aro A, Albanes D, Huttunen JK. Prospective study of diet, lifestyle, and intermittent claudication in male smokers. Am J Epidemiol 2000;151:892-901.
69. van Herpen-BroekmansWMR, Klopping-Ketelaars IAA, BotsML, Kluft C, Princen H, Hendriks HFJ, Tijburg LBM, van Poppel G, Kardinaal AFM. Serum carotenoids and vitamins in relation to markers of endothelial function and inflammation. Eur J Epidemiol 2004;19:915-21.
70. Wang L, Liu SM, Pradhan AD, Manson JE, Buring JE, Gaziano JM, Sesso HD. Plasma lycopene, other carotenoids, and the risk of type 2 diabetes in women. Am J Epidemiol 2006;164:576-85.
71. Wang MX, Jiao JH, Li ZY, Liu RR, Shi Q, Ma L. Lutein supplementation reduces plasma lipid peroxidation and C-reactive protein in healthy nonsmokers. Atherosclerosis 2013;227:380-5.
72. Wang Y, Chung SJ, McCullough ML, Song WO, Fernandez ML, Koo SI, Chun OK. Dietary carotenoids are associated with cardiovascular disease risk biomarkers mediated by serum carotenoid concentrations. J Nutr 2014;144:1067-74.
73. Waters D, Clark RM, Greene CM, Contois JH, Fernandez ML. Change in plasma lutein after egg consumption is positively associated with plasma cholesterol and lipoprotein size but negatively correlated with body size in postmenopausal women. J Nutr 2007;137:959-63.
74. Xu XR, Zou ZY, Huang YM, Xiao X, Ma L, Lin XM. Serum carotenoids in relation to risk factors for development of atherosclerosis. Clin Biochem 2012;45:1357-61.
75. Xu XR, Zou ZY, Xiao X, Huang YM, Wang X, Lin XM. Effects of lutein supplement on serum inflammatory cytokines, apoE and lipid profiles in early atherosclerosis population. J Atheroscler Thromb 2013;20:170-7.
76. Yeon JY, Kim HS, Sung MK. Diets rich in fruits and vegetables suppress blood biomarkers of metabolic stress in overweight women. Prev Med 2012;54(Suppl):S109-15.
77. Zou Z, Xu XR, Huang YM, Xiao X, Ma L, Sun TT, Dong PC, Wang X, Lin XM. High serum level of lutein may be protective against early atherosclerosis: the Beijing atherosclerosis study. Atherosclerosis 2011;219:789-93.
78. Zou ZY, Xu XR, Lin XM, Zhang HB, Xiao X, Ouyang L, Huang YM, Wang X, Liu YQ. Effects of lutein and lycopene on carotid intimamedia thickness in Chinese subjects with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial. Br J Nutr 2014; 111:474-80.
79. Quality assessment tool for quantitative studies: National Collaborating Centre for Methods and Tools [Internet]. Hamilton (Canada): McMaster University; 2008. [cited 2010 Apr 13]. Available from http://www.nccmt.ca/registry/view/eng/14.htm.l.
80. Carter P, Gray LJ, Troughton J, Khunti K, Davies MJ. Fruit and vegetable intake and incidence of type 2 diabetes mellitus: systematic review and meta-analysis. BMJ 2010;341:c4229.
81. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, Creactive protein, albumin, or leukocyte count with coronary heart disease-meta-analyses of prospective studies. JAMA 1998;279:1477-82.
82. Chêne G, Binquet C, Moreau JF, Neau D, Pellegrin I, Malvy D, CeccalDi J, Lacoste D, Dabis F, Aquitaine GECS. Changes in CD4+ cell count and the risk of opportunistic infection or death after highly active antiretroviral treatment. AIDS 1998;12:2313-20.
83. Higgins JPT, Thompson SG. Quantifying heterogeneity in a metaanalysis. Stat Med 2002;21:1539-58.
84. Ogilvie D, Fayter D, Petticrew M, Sowden A, Thomas S, Whitehead M, Worthy G. The harvest plot: a method for synthesising evidence about the differential effects of interventions. BMC Med Res Methodol 2008;8:8.
85. Facchini FS, Hollenbeck CB, Jeppesen J, Chen YDI, Reaven GM. Insulin resistance and cigarette smoking. Lancet 1992;339:1128-30.
86. Attvall S, Fowelin J, Lager I, Vonschenck H, Smith U. Smoking induces insulin resistance-a potential link with the insulin resistance syndrome. J Intern Med 1993;233:327-32.
87. Ford ES, Mokdad AH, Giles WH, Brown DW. The metabolic syndrome and antioxidant concentrations-finDings from the Third National Health and Nutrition Examination Survey. Diabetes 2003;52: 2346-52.
88. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004;114:1752-61.
89. Van Guilder GP, Hoetzer GL, Greiner JJ, Stauffer BL, Desouza CA. Influence of metabolic syndrome on biomarkers of oxidative stress and inflammation in obese adults. Obesity (Silver Spring) 2006;14(12): 2127-31.
90. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL. Markers of inflammation and cardiovascular disease application to clinical and public health practice-a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511.
91. Lagrand WK, Visser CA, Hermens WT, Niessen HW, Verheugt FW, Wolbink GJ, Hack CE. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation 1999;100:96-102.
92. Pérez-Rodríguez L. Carotenoids in evolutionary ecology: reevaluating the antioxidant role. BioEssays 2009;31:1116-26.
93. Jyonouchi H, Zhang L, Gross M, Tomita Y. Immunomodulating actions of carotenoids-enhancement of in-vivo and in-vitro antibodyproduction to T-dependent antigens. Nutr Cancer 1994;21:47-58.
94. Kim HW, Chew BP, Wong TS, Park JS, Weng BC, Byrne KM, Hayek MG, Reinhart GA. Modulation of humoral and cell-mediated immune responses by dietary lutein in cats. Vet Immunol Immunopathol 2000; 73:331-41.
95. Kim HW, Chew BP, Wong TS, Park JS, Weng BBC, Byrne KM, Hayek MC, Reinhart GA. Dietary lutein stimulates immune response in the canine. Vet Immunol Immunopathol 2000;74:315-27.
96. McGraw KJ, Ardia DR. Carotenoids, immunocompetence, and the information content of sexual colors: an experimental test. Am Nat 2003;162:704-12.
97. Kowluru RA, Menon B, Gierhart DL. Beneficial effect of zeaxanthin on retinal metabolic abnormalities in diabetic rats. Invest Ophthalmol Vis Sci 2008;49:1645-51.
98. Izumi-Nagai K, Nagai N, Ohgami K, Satofuka S, Ozawa Y, Tsubota K, Umezawa K, Ohno S, Oike Y, Ishida S. Macular pigment lutein is antiinflammatory in preventing choroidal neovascularization. Arterioscler Thromb Vasc Biol 2007;27:2555-62.
99. Gruber M, Chappell R, Millen A, LaRowe T, Moeller SM, Iannaccone A, Kritchevsky SB, Mares J. Correlates of serum lutein plus zeaxanthin: finDings from the Third National Health and Nutrition Examination Survey. J Nutr 2004;134(9):2387-94.